Optical Membrane Pressure Sensing for Closed Microfluidic Processing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current manufacturing technologies for polynucleotide therapeutics face challenges such as contamination, high costs, and inefficiencies in centralized production, which can lead to suboptimal therapeutic formulations, particularly for individualized care.
Innovation Solution
The development of microfluidic systems equipped with devices and methods for measuring fluid pressure, utilizing flexible membranes and optical features to deform in response to fluid properties, allowing for precise tracking and processing of therapeutic polynucleotides in a closed, aseptic environment for point-of-care operations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If centralized production is used for polynucleotide therapeutics, then manufacturing scale is improved, but contamination risk and cost increase
Solution Approach 1:
The patent divides the manufacturing process into distributed microfluidic units that can operate independently, eliminating the need for large centralized facilities. Each microfluidic device processes small volumes in isolated chambers, reducing contamination risk while maintaining overall production capacity through parallel operation of multiple units.
Solution Approach 2:
The patent introduces automated liquid handling robots and pre-filled cartridges as intermediaries between reagent storage and reaction chambers. These intermediaries minimize human touchpoints and manual operations, thereby reducing contamination risk while enabling scalable production through automated workflows.
2Productivity
If centralized production is used for polynucleotide therapeutics, then manufacturing scale is improved, but production time increases
Solution Approach 1:
The manufacturing process is segmented into parallel microfluidic reaction channels that can simultaneously process multiple samples. This parallelization enables scalable production without proportionally increasing production time, as multiple therapeutic formulations can be generated concurrently in different chambers of the same device.
Solution Approach 2:
The patent employs pre-filled reagent cartridges and pre-programmed robotic liquid handlers that perform preparation steps before the actual synthesis begins. This preliminary action reduces setup time and enables faster initiation of production, thereby decreasing overall production time while maintaining scalable output.
3Adaptability or versatility
If manual handling is used in polynucleotide manufacturing, then process flexibility is improved, but contamination risk increases
Solution Approach 1:
The microfluidic devices are designed with integrated valves, pumps, and mixing chambers that automatically control fluid flow and reactions without manual intervention. The system self-regulates reaction conditions and timing, maintaining process flexibility through programmable control while eliminating contamination risks associated with manual handling.
Solution Approach 2:
The patent replaces manual mechanical operations with automated robotic liquid handlers and electronically controlled microfluidic valves. This substitution maintains the flexibility to program different protocols while eliminating human touchpoints, thereby preserving adaptability while reducing contamination risk.
4Measurement precision
If optical features are added to flexible membrane for pressure sensing, then measurement capability is improved, but device complexity increases
Solution Approach 1:
The patent combines the flexible membrane structure with optical features into a single integrated component. The optical elements (such as transparent regions or embedded markers) are incorporated directly into the membrane, allowing pressure-induced deformation to be optically detected without requiring separate sensing mechanisms, thereby reducing overall device complexity.
Solution Approach 2:
The flexible membrane serves multiple functions: it acts as both the structural barrier separating fluid chambers and the sensing element for pressure measurement. By making the membrane itself optically detectable through integrated features, the design eliminates the need for separate pressure sensors, reducing device complexity while maintaining measurement precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables scalable, efficient, and contamination-free production of therapeutic polynucleotides, ensuring high reproducibility and individualized dosages by accurately measuring fluid pressure and properties within microfluidic systems, thereby enhancing the manufacturing and formulation processes.
Implementation Method 1
The flexible membrane is to deform along a lateral dimension using at least the pressure of fluid in the sensing region
Implementation Method 2
The optical feature includes a first optical pattern on the flexible membrane. The first optical pattern is to provide varying optical interference with a second optical pattern using at least a degree of deformation of the flexible membrane along the lateral dimension
Implementation Method 3
The optical feature includes a diffractive element on the flexible membrane
Data Source
AI summary
An apparatus includes a sensing region. A flexible membrane positioned in the sensing region defines a plane, a radial center, and a central axis extending perpendicularly relative to the plane at the radial center. The membrane deforms along the central axis and along a lateral dimension using at least a property of fluid (e.g., pressure or density) in the sensing region. The lateral dimension is transverse to the central axis. An optical feature changes a visual state in response to deformation of the membrane along the lateral dimension. A camera is positioned to view the optical feature and capture images of the optical feature.